ERBB2 and mucinous adenocarcinoma: Instead, activation status of EGF receptors might be more important, while in mucinous adenocarcinomas, the constitutive activation of the ERBB2 pathway, which is caused by persistent up-regulation of ERBB2 and ERBB2 mutations, might contribute to the MUC5AC overexpression.